Mylan N.V. (MYL) Receives “Hold” Rating from Royal Bank Of Canada
Mylan N.V. (NASDAQ:MYL)‘s stock had its “hold” rating reissued by equities researchers at Royal Bank Of Canada in a research note issued on Friday. They presently have a $33.00 price target on the stock, down from their previous price target of $41.00. Royal Bank Of Canada’s price objective would indicate a potential upside of 3.81% from the stock’s current price.
Several other research firms have also recently commented on MYL. Wells Fargo & Company reissued a “market perform” rating and set a $40.00 target price on shares of Mylan N.V. in a research note on Wednesday, May 31st. Zacks Investment Research raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, May 25th. BidaskClub raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, June 22nd. Barclays PLC raised shares of Mylan N.V. from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $47.00 to $50.00 in a research note on Monday, May 22nd. Finally, Cowen and Company reissued a “market perform” rating and set a $43.00 target price (down previously from $55.00) on shares of Mylan N.V. in a research note on Sunday, May 21st. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $50.21.
Shares of Mylan N.V. (MYL) opened at 31.79 on Friday. The stock has a market cap of $17.04 billion, a P/E ratio of 31.76 and a beta of 1.27. The company’s 50-day moving average is $38.19 and its 200-day moving average is $39.19. Mylan N.V. has a 12-month low of $31.28 and a 12-month high of $50.40. Mylan N.V. also was the recipient of some unusual options trading activity on Monday. Stock traders bought 9,410 call options on the stock. This is an increase of approximately 250% compared to the typical daily volume of 2,688 call options.
Mylan N.V. (NASDAQ:MYL) last released its earnings results on Wednesday, May 10th. The company reported $0.93 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.92 by $0.01. The firm had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.81 billion. Mylan N.V. had a net margin of 4.59% and a return on equity of 23.69%. Mylan N.V.’s quarterly revenue was up 24.1% on a year-over-year basis. During the same quarter last year, the company earned $0.76 EPS. On average, analysts expect that Mylan N.V. will post $5.12 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was first published by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dailypolitical.com/2017/08/08/mylan-n-v-nasdaqmyl-given-a-33-00-price-target-at-royal-bank-of-canada.html.
In related news, insider Anthony Mauro sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the completion of the sale, the insider now directly owns 140,653 shares in the company, valued at $5,626,120. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Rajiv Malik sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the sale, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The disclosure for this sale can be found here. Company insiders own 0.69% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. First Personal Financial Services boosted its stake in Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock valued at $107,000 after buying an additional 681 shares in the last quarter. Global X Management Co. LLC boosted its stake in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock valued at $118,000 after buying an additional 1,441 shares in the last quarter. Ropes Wealth Advisors LLC bought a new stake in Mylan N.V. during the first quarter valued at approximately $136,000. Oakworth Capital Inc. boosted its stake in Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock valued at $166,000 after buying an additional 1,000 shares in the last quarter. Finally, State of Alaska Department of Revenue bought a new stake in Mylan N.V. during the first quarter valued at approximately $188,000. Institutional investors and hedge funds own 70.19% of the company’s stock.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.